This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Intercept Pharmaceuticals, Inc., Studiengesellschaft Kohle Mbh. Active years: 2020-2026.
Company Filing History:
1 out of 62 
1 out of 203 Years Active: 2020-2026
Title: Innovations of Chandra Kanta De in Pharmaceutical Chemistry
Introduction
Chandra Kanta De is a notable inventor based in Muelheim an der Ruhr, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of bile acid derivatives. His work is characterized by a focus on safe and efficient methods for producing important pharmaceutical compounds.
Latest Patents
Chandra Kanta De holds a patent for "Methods for the preparation of obeticholic acid and derivatives thereof." This patent describes a safe method of preparing a bile acid derivative or a pharmaceutical acceptable salt, solvate, or amino acid conjugate from 7-keto lithocholic acid (KLCA). The process involves reacting Compound 2 with paraldehyde to form Compound 3 at a temperature between 10°C and 30°C. This innovation is crucial for large-scale production in the pharmaceutical industry.
Career Highlights
Chandra Kanta De is currently employed at Intercept Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical development. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Chandra Kanta De has collaborated with esteemed colleagues such as Benjamin List and Qinggang Wang. These partnerships have fostered an environment of innovation and have contributed to the advancement of research in pharmaceutical chemistry.
Conclusion
Chandra Kanta De's contributions to the field of pharmaceutical chemistry, particularly through his patent on obeticholic acid, highlight his role as an influential inventor. His work continues to impact the development of important pharmaceutical compounds.